U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06803823) titled 'A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia' on Jan. 27.
Brief Summary: To evaluate the efficacy and safety of ONO-2020 in patients with agitation associated with Alzheimer's Disease dementia in Japan.
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Agitation Associated With Alzheimer's Disease Dementia
Intervention:
DRUG: ONO-2020
ONO-2020 group: Two ONO-2020 tablets will be orally administered once daily.
DRUG: Placebo
Two ONO-2020 placebo tablets will be orally administered once daily
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ono Pharmaceutical Co. Lt...